sharesgurusharesguru
  • Stocks
  • Ai Screener
  • Sectors
  • Watchlist
LoginSign Up
sharesguru
  • Home
  • Stocks
  • Ai Screener
  • Sectors
  • Watchlist
  • Profile
  • Contact Us
LoginSign Up
sharesguru

Discover the joy of investing.

All the financial data and tools you need, at one place.

Navigation

  • Home
  • Stocks
  • Sectors

Tools

  • Ai Screener
  • Watchlists

Company

  • Contact

Legal

  • Privacy Policy
  • Terms of Service
Copyright © 2025 Knowtilus Technologies Pvt. Ltd.
SummaryLatest NewsSector ComparisonEarnings ReportRevenue & GrowthPeersIncome StatementBalance SheetCash Flow
APOLLOHOSP

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

Healthcare Services

₹7111.50+69.00(+0.98%)
Market Closed as of Jan 1, 2026, 15:30 IST
Pros

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Past Returns: In past three years, the stock has provided 16.3% return compared to 13% by NIFTY 50.

Balance Sheet: Strong Balance Sheet.

Technicals: Bullish SharesGuru indicator.

Size: It is among the top 200 market size companies of india.

Growth: Good revenue growth. With 53.3% growth over past three years, the company is going strong.

Cons

Momentum: Stock is suffering a negative price momentum. Stock is down -3.4% in last 30 days.

Valuation

Market Cap1.01 LCr
Price/Earnings (Trailing)60.55
Price/Sales (Trailing)4.31
EV/EBITDA29.94
Price/Free Cashflow266.05
MarketCap/EBT44.53
Enterprise Value1.06 LCr

Fundamentals

Revenue (TTM)23.48 kCr
Rev. Growth (Yr)13%
Earnings (TTM)1.73 kCr
Earnings Growth (Yr)24.8%

Profitability

Operating Margin10%
EBT Margin10%
Return on Equity18.1%
Return on Assets7.88%
Free Cashflow Yield0.38%

Price to Sales Ratio

Latest reported: 4.3

Revenue (Last 12 mths)

Latest reported: 23.5 kCr

Net Income (Last 12 mths)

Latest reported: 1.7 kCr

Growth & Returns

Price Change 1W-1.8%
Price Change 1M-3.4%
Price Change 6M-6.8%
Price Change 1Y-3.5%
3Y Cumulative Return16.3%
5Y Cumulative Return23.9%
7Y Cumulative Return27.9%
10Y Cumulative Return17%

Cash Flow & Liquidity

Cash Flow from Investing (TTM)-3.38 kCr
Cash Flow from Operations (TTM)2.14 kCr
Cash Flow from Financing (TTM)1.32 kCr
Cash & Equivalents488.4 Cr
Free Cash Flow (TTM)423.7 Cr
Free Cash Flow/Share (TTM)29.47

Balance Sheet

Total Assets21.95 kCr
Total Liabilities12.4 kCr
Shareholder Equity9.55 kCr
Current Assets8.02 kCr
Current Liabilities4.76 kCr
Net PPE9.96 kCr
Inventory505.4 Cr
Goodwill1.03 kCr

Capital Structure & Leverage

Debt Ratio0.24
Debt/Equity0.56
Interest Coverage4.14
Interest/Cashflow Ops5.74

Dividend & Shareholder Returns

Dividend/Share (TTM)19
Dividend Yield0.27%
Shares Dilution (1Y)0.00%
Shares Dilution (3Y)0.00%
Pros

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Past Returns: In past three years, the stock has provided 16.3% return compared to 13% by NIFTY 50.

Balance Sheet: Strong Balance Sheet.

Technicals: Bullish SharesGuru indicator.

Size: It is among the top 200 market size companies of india.

Growth: Good revenue growth. With 53.3% growth over past three years, the company is going strong.

Cons

Momentum: Stock is suffering a negative price momentum. Stock is down -3.4% in last 30 days.

The Good, Bad and Ugly
Growth
Measures how quickly a company is expanding through metrics like revenue growth, earnings growth, and cash flow growth over time. Strong growth can indicate future potential.
Profitability
Shows how efficiently a company turns business activities into profit, using metrics like profit margins, return on equity (ROE), and return on assets (ROA).
Size
Indicates the company's market presence through metrics like market capitalization, total assets, and revenue. Size can influence stability and market influence.
Dilution Rank
Tracks how much the company's shares have increased or decreased over time. Lower dilution means existing shareholders maintain stronger ownership stakes.
Balance Sheet
Evaluates the company's financial health by analyzing assets, debts, and equity. A strong balance sheet indicates financial stability and flexibility.
Momentum
Measures the strength and speed of price movements, showing whether the stock is gaining or losing market favor over different time periods.
Technicals
Analyzes price patterns, trading volumes, and other market indicators to identify potential trading opportunities and market trends.
Smart Money
Tracks the investment activities of institutional investors, hedge funds, and other large financial players who often have deep research capabilities.
Insider Trading
Monitors buying and selling of company shares by executives, directors, and other insiders who may have unique insights into the company's prospects.

Investor Care

Dividend Yield0.27%
Dividend/Share (TTM)19
Shares Dilution (1Y)0.00%
Earnings/Share (TTM)116.28

Financial Health

Current Ratio1.68
Debt/Equity0.56

Technical Indicators

RSI (14d)51.47
RSI (5d)44.98
RSI (21d)38.45
MACD SignalBuy
Stochastic Oscillator SignalHold
Grufity SignalSell
RSI SignalHold
RSI5 SignalHold
RSI21 SignalHold
SMA 5 SignalSell
SMA 10 SignalSell
SMA 20 SignalSell
SMA 50 SignalSell
SMA 100 SignalSell

Latest News and Updates from Apollo Hospitals Enterprises

Updated May 4, 2025

The Bad News

Source-Mint

The stock is trading 0.55% lower and has seen a year-to-date decline of 4.38%.

Source-Mint

Mutual fund and foreign institutional investor holdings have decreased to 12.77% and 45.27%, respectively.

Source-Mint

The company's TTM P/E ratio of 80.08 is significantly higher than the sector average of 23.01, raising concerns about its valuation.

The Good News

Source-The Financial Express

Apollo Hospitals Enterprise has shown a robust five-year performance with an increase of 406.03%.

Source-The Financial Express

The stock has demonstrated a monthly return of 5.17%, indicating some recovery in recent weeks.

Source-Mint

Among 24 analysts, 21 recommend a buy or strong buy for the stock, reflecting a level of confidence in its long-term prospects.

Updates from Apollo Hospitals Enterprises

General • 24 Dec 2025
As per annexure enclosed
General • 24 Dec 2025
As per annexure enclosed
Analyst / Investor Meet • 11 Nov 2025
as per annexure enclosed
General • 08 Nov 2025
as per annexure enclosed
Analyst / Investor Meet • 07 Nov 2025
as per annexure enclosed
Analyst / Investor Meet • 06 Nov 2025
as per annexure enclosed
Investor Presentation • 06 Nov 2025
as per annexure enclosed

This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.

Summary of Latest Earnings Report from Apollo Hospitals Enterprises

Summary of Apollo Hospitals Enterprises's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Last updated:

Last updated:

Revenue Breakdown

Analysis of Apollo Hospitals Enterprises's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.

Last Updated: Sep 30, 2025

DescriptionShareValue
a) Healthcare services50.7%3.2 kCr
c) Digital health and pharmacy distribution41.9%2.7 kCr
b) Retail health and diagnostics7.5%473.9 Cr
Total6.4 kCr

Share Holdings

Understand Apollo Hospitals Enterprises ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Share Holding Details

Shareholder NameHolding %
M/s. PCR Investments Ltd18.93%
Ms. Suneeta Reddy2.04%
AXIS MUTUAL FUND TRUSTEE LTD1.9%
MIRAE ASSET ELSS TAX SAVER FUND1.74%
Ms. Sangita Reddy1.69%
Ms. Shobana Kamineni1.56%
SBI ARBITRAGE OPPORTUNITIES FUND1.51%
HDFC TRUSTEE COMPANY LTD1.4%
GOVERNMENT PENSION FUND GLOBAL1.4%
GOVERNMENT OF SINGAPORE - E1.37%
NIPPON LIFE INDIA TRUSTEE LTD1.31%
INVESCO INDIA ELSS TAX SAVER FUND1.29%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LTD1.28%
FRANKLIN INDIA LARGE & MID CAP FUND1.11%
Mr. K Vishweshwar Reddy1.1%
Ms. Preetha Reddy0.73%
Mr. Karthik Anand0.24%
Mr. Harshad Reddy0.23%
Ms. Sindoori Reddy0.22%
Ms. Anuspala Kamineni0.18%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Apollo Hospitals Enterprises Better than it's peers?

Detailed comparison of Apollo Hospitals Enterprises against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker
Name
Mkt Cap
Revenue
Price %, 1M
Returns, 1Y
P/E
P/S
Rev 1-Yr
Inc 1-Yr
MAXHEALTHMax Healthcare Institute1.02 LCr8.09 kCr-7.10%-7.40%74.8612.56--
FORTISFortis Healthcare66.8 kCr8.51 kCr-2.20%+22.90%65.887.85--
NHNarayana Hrudayalaya38.65 kCr6.09 kCr-1.00%+48.60%45.456.35--
MEDANTAGlobal Health31.89 kCr4.08 kCr-4.80%+10.00%56.777.81--
LALPATHLABDr. Lal Pathlabs24.78 kCr2.7 kCr-3.10%-1.40%46.159.17--
KIMSKrishna Institute of Medical Sciences24.21 kCr3.44 kCr-12.30%+1.20%72.127.05--
METROPOLISMetropolis Healthcare9.99 kCr1.5 kCr-1.40%-7.10%62.896.66--

Sector Comparison: APOLLOHOSP vs Healthcare Services

Comprehensive comparison against sector averages

Comparative Metrics

APOLLOHOSP metrics compared to Healthcare

CategoryAPOLLOHOSPHealthcare
PE60.5560.61
PS4.316.44
Growth14 %11.8 %
0% metrics above sector average
Key Insights
  • 1. APOLLOHOSP is among the Top 3 Hospital companies by market cap.
  • 2. The company holds a market share of 33.1% in Hospital.
  • 3. In last one year, the company has had an above average growth that other Hospital companies.

Income Statement for Apollo Hospitals Enterprises

Consolidated figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Revenue From Operations14.4%21,79419,05916,61214,66310,56011,247
Other Income89.5%20010690784527
Total Income14.8%21,99419,16616,70314,74110,60511,274
Cost of Materials12.2%2,7542,4542,2842,6851,6231,809
Purchases of stock-in-trade15.9%8,5577,3856,3154,9614,1863,797
Employee Expense11%2,7692,4942,1441,7871,6011,853
Finance costs2%458449381379449533
Depreciation and Amortization10.3%758687615601573620
Other expenses7.4%4,6934,3693,8453,1182,1372,308
Total Expenses12.3%19,98817,80515,55913,45710,44510,812
Profit Before exceptional items and Tax47.4%2,0061,3611,1441,284160462
Exceptional items before tax-211.1%01.9029461198
Total profit before tax47.3%2,0061,3621,1441,578221660
Current tax20.4%52643740623876214
Deferred tax-13%7.78.7-149.672398.9211
Total tax19.8%53444625647785225
Total profit (loss) for period61%1,5059358451,108137432
Other comp. income net of taxes36%-6.3-10.4-13.27-9.7215-0.6
Total Comprehensive Income62.1%1,4999258311,099152431
Earnings Per Share, Basic61.9%100.5662.556.9773.4210.7432.7
Earnings Per Share, Diluted61.9%100.5662.556.9773.4210.7432.7
Description(%) Q/QSep-2025Jun-2025Mar-2025Dec-2024Sep-2024Jun-2024
Revenue From Operations7.9%6,3045,8425,5925,5275,5895,086
Other Income38.5%554061643837
Total Income8.1%6,3585,8825,6535,5915,6285,123
Cost of Materials5.3%779740694626744690
Purchases of stock-in-trade6.4%2,4652,3162,2442,2922,1101,911
Employee Expense7.6%767713725686700658
Finance costs1.9%110108115110118116
Depreciation and Amortization1.4%218215211185184177
Other expenses9.9%1,3521,2301,1691,1781,2161,129
Total Expenses7.1%5,6905,3135,1485,0605,0764,704
Profit Before exceptional items and Tax17.4%668569505531552418
Exceptional items before tax-000000
Total profit before tax17.4%668569505531552418
Current tax29.8%162125119134160113
Deferred tax12.5%1917-18221.91.5
Total tax27.7%181142101157162114
Total profit (loss) for period12%494441414379396316
Other comp. income net of taxes1042.9%575.9-3-2.9-5.55.2
Total Comprehensive Income23.3%551447412376390321
Earnings Per Share, Basic10.6%33.1930.127.125.8926.3421.23
Earnings Per Share, Diluted10.6%33.1930.127.125.8926.3421.23
Standalone figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Revenue From Operations12.8%8,2027,2746,5256,0989,1539,794
Other Income93.9%348180152471811
Total Income14.7%8,5507,4546,6766,1459,1719,805
Cost of Materials12.5%2,2481,9991,8611,9291,3301,532
Purchases of stock-in-trade-00004,1553,754
Employee Expense12.1%1,5971,4251,2391,1501,2751,519
Finance costs1.6%254250239244344426
Depreciation and Amortization12.6%449399367363436482
Other expenses12.7%2,3132,0521,7431,5991,5731,678
Total Expenses12%6,8616,1255,4495,2868,9859,287
Profit Before exceptional items and Tax27%1,6881,3291,228859186518
Exceptional items before tax-000-6.74-9.09164
Total profit before tax27%1,6881,3291,228852177682
Current tax26.2%4063223024062205
Deferred tax-217.8%-13.3-3.5-159.772399.486.94
Total tax23.3%39231814328072212
Total profit (loss) for period28.3%1,2961,0101,085665105470
Other comp. income net of taxes91.6%0.2-8.5-11.14-2.24-5.580.75
Total Comprehensive Income29.4%1,2961,0021,074663100471
Earnings Per Share, Basic28.7%90.1570.2875.4546.267.5133.8
Earnings Per Share, Diluted28.7%90.1570.2875.4546.267.5133.8
Debt equity ratio---025-082082
Debt service coverage ratio---0.0231-0.02920.0292
Interest service coverage ratio---0.0713-0.04270.0427
Description(%) Q/QSep-2025Jun-2025Mar-2025Dec-2024Sep-2024Jun-2024
Revenue From Operations8.7%2,3562,1682,0752,0552,1351,937
Other Income351.6%141329210812127
Total Income13.5%2,4972,2002,1672,1632,2561,964
Cost of Materials3.6%611590562569581536
Employee Expense6.7%431404410394412381
Finance costs-1.7%585963626564
Depreciation and Amortization-0.8%122123130108108103
Other expenses14.8%721628582580602549
Total Expenses7.8%1,9441,8041,7471,7131,7691,632
Profit Before exceptional items and Tax39.6%554397420449488332
Total profit before tax39.6%554397420449488332
Current tax38.6%123899910512081
Deferred tax1766.7%110.4-12.62.6-2.2-1.1
Total tax49.4%134908710811880
Total profit (loss) for period36.9%420307333342370252
Other comp. income net of taxes-293.6%-8.15.70.1-2.5-2.45
Total Comprehensive Income31.7%412313334339367257
Earnings Per Share, Basic38.6%29.221.3523.1823.7625.7117.51
Earnings Per Share, Diluted38.6%29.221.3523.1823.7625.7117.51
Debt equity ratio-------
Debt service coverage ratio-------
Interest service coverage ratio-------

Balance Sheet for Apollo Hospitals Enterprises

Consolidated figures (in Rs. Crores) /
Description(%) Q/QSep-2025Mar-2025Sep-2024Mar-2024Sep-2023Mar-2023
Cash and cash equivalents-15.6%4885781,435506472433
Current investments31.2%1,8781,432698684562292
Loans, current-58.5%2.75.134.95.675.63
Total current financial assets16.1%6,9635,9966,5144,3044,1173,602
Inventories5%505481448460423390
Current tax assets-2080--252-
Total current assets14.1%8,0237,0297,3385,2805,1404,337
Property, plant and equipment1.5%9,9659,8169,0438,5407,7717,432
Capital work-in-progress33.1%1,0267711,042845727602
Investment property-16.7%2.52.83.13.43.754.06
Goodwill0.2%1,0321,0301,0121,0121,011986
Non-current investments8.7%90283031410429096
Loans, non-current38.5%3727316.66.98.37
Total non-current financial assets11.5%1,1931,070629363614401
Total non-current assets2.2%13,92713,62812,21011,47310,42110,091
Total assets6.3%21,95020,65719,54816,75315,56114,428
Borrowings, non-current1.5%4,4834,4173,8192,2362,0161,938
Total non-current financial liabilities2.2%7,0116,8626,0814,2274,4094,052
Provisions, non-current17%1048981735657
Total non-current liabilities2.8%7,6337,4266,6324,7684,9044,572
Borrowings, current0%8588581,029926994773
Total current financial liabilities3.4%4,2754,1344,5684,2833,3422,972
Provisions, current9%195179166143174113
Current tax liabilities183.3%2.71.60.81.34.052.8
Total current liabilities4%4,7644,5795,0014,6643,7803,325
Total liabilities3.3%12,39712,00411,6339,4338,6837,896
Equity share capital0%727272727272
Non controlling interest4.3%460441414385369334
Total equity10.4%9,5538,6537,9157,3206,8786,531
Total equity and liabilities6.3%21,95020,65719,54816,75315,56114,428
Standalone figures (in Rs. Crores) /
Description(%) Q/QSep-2025Mar-2025Sep-2024Mar-2024Sep-2023Mar-2023
Cash and cash equivalents-33.2%156233325276254217
Current investments31.2%1,8781,432697684562292
Loans, current-42.9%1322113798080
Total current financial assets16.7%3,6693,1433,0543,2803,1862,820
Inventories4.8%13312712711911298
Current tax assets-220--63-
Total current assets14.6%4,0323,5183,3723,6753,5063,151
Property, plant and equipment1%6,2996,2395,9535,9715,3555,049
Capital work-in-progress32.8%3902942951729789
Goodwill-000000
Non-current investments1.9%2,5252,4792,4671,9381,9381,925
Loans, non-current25.7%539429360245225236
Total non-current financial assets4.9%3,2123,0612,9852,3612,4002,292
Total non-current assets2.9%10,1359,8549,4788,7307,9947,630
Total assets5.9%14,16713,37212,85012,40511,50010,780
Borrowings, non-current2.1%1,5861,5541,6811,7861,6211,520
Total non-current financial liabilities2%2,8892,8332,8412,9442,5772,225
Total non-current liabilities2.1%3,2633,1973,2163,3242,9492,612
Borrowings, current-9.2%209230205170175240
Total current financial liabilities10.1%1,3001,1811,2071,1611,0351,062
Provisions, current9.4%14012812310112377
Total current liabilities10.3%1,5891,4411,4441,3701,2571,243
Total liabilities4.6%4,8524,6384,6594,6944,2063,856
Equity share capital0%727272727272
Total equity6.7%9,3158,7348,1907,7117,2946,925
Total equity and liabilities5.9%14,16713,37212,85012,40511,50010,780

Cash Flow for Apollo Hospitals Enterprises

Consolidated figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Finance costs2%458449381379--
Change in inventories68.7%-21-69.242-175.76--
Depreciation10.3%758687615601--
Impairment loss / reversal-2001.78--
Unrealised forex losses/gains0%0.10.1-0.29-0.55--
Dividend income-0.7000--
Adjustments for interest income116.7%92434435--
Share-based payments28.7%11388762.56--
Net Cashflows from Operations10.2%2,6302,3871,7591,820--
Income taxes paid (refund)5.8%494467382204--
Net Cashflows From Operating Activities11.3%2,1361,9201,3771,616--
Cashflows used in obtaining control of subsidiaries-137%03.750100--
Proceeds from sales of PPE1455.6%151.94.070--
Purchase of property, plant and equipment50.7%1,7131,1371,129657--
Proceeds from sales of investment property-0005.4--
Proceeds from sales of long-term assets-100.1%081700--
Purchase of other long-term assets-100.1%01,17100--
Cash receipts from repayment of advances and loans made to other parties-50.7%8.4162.9811--
Dividends received-9.805.040--
Interest received118.4%84394436--
Other inflows (outflows) of cash-308.3%-353.8-85.949-153.66--
Net Cashflows From Investing Activities-119.9%-3,380.6-1,537.1-856.85-790.73--
Proceeds from changes in ownership interests in subsidiaries-004.540--
Payments from changes in ownership interests in subsidiaries-89.2%2.41401--
Proceeds from issuing shares3114.3%462.400--
Proceeds from borrowings261.2%2,551707585426--
Repayments of borrowings74.3%442254516712--
Payments of lease liabilities-256019760--
Dividends paid25.9%27822125843--
Interest paid-0.3%302303251376--
Other inflows (outflows) of cash-1000--
Net Cashflows from Financing Activities521.5%1,317-311.2-633.33-767.7--
Net change in cash and cash eq.1.4%7372-113.1357--
Standalone figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Finance costs1.6%254250239249--
Change in inventories58.4%-7.9-20.449-166.45--
Depreciation12.6%449399367400--
Impairment loss / reversal-200-1.6--
Unrealised forex losses/gains33.3%0.40.1-0.23-0.51--
Dividend income74.3%177102610.39--
Adjustments for interest income130.6%84374119--
Net Cashflows from Operations38.4%2,1041,5211,5481,299--
Income taxes paid (refund)9.7%36233032398--
Net Cashflows From Operating Activities46.3%1,7421,1911,2241,201--
Cashflows used in obtaining control of subsidiaries-543000--
Proceeds from sales of PPE12900%141.12.334.99--
Purchase of property, plant and equipment38.2%858621396463--
Proceeds from sales of long-term assets-100.1%081700--
Purchase of other long-term assets-100.1%01,18000--
Cash receipts from repayment of advances and loans made to other parties1133.3%186161612--
Dividends received74.3%177102610.39--
Interest received216.7%58192421--
Other inflows (outflows) of cash-970%-294.835129-28.34--
Net Cashflows From Investing Activities-25.2%-1,045.7-835.3-588.23-444.6--
Proceeds from borrowings-100.2%0464150401--
Repayments of borrowings-35.8%173269414658--
Payments of lease liabilities10.1%110100850--
Dividends paid26.5%27321625543--
Interest paid4%183176175248--
Net Cashflows from Financing Activities-148.4%-739.1-297-778.62-637.22--
Net change in cash and cash eq.-175.7%-42.959-142.62119--

What does Apollo Hospitals Enterprises Ltd. do?

Hospital•Healthcare•Mid Cap

Apollo Hospitals Enterprises is a prominent healthcare company based in Chennai, India, with the stock ticker APOLLOHOSP and a market capitalization of Rs. 101,296.5 Crores. The company was established in 1979 and operates both domestically and internationally in various segments of healthcare.

Core Operations
Apollo Hospitals Enterprise Limited, along with its subsidiaries, provides a broad range of healthcare services through several segments, including:

  • Healthcare Services
  • Retail Health & Diagnostics
  • Digital Health & Pharmacy Distribution

Its healthcare facilities deliver primary, secondary, and tertiary care, along with a variety of specialty services. Some key areas of specialization include:

  • Cardiac sciences
  • Orthopedics
  • Oncology
  • Neurosciences
  • Emergency services
  • Robotic surgery
  • Transplants

Additionally, the company offers numerous other healthcare services in fields like cardiology, neurology, gastroenterology, and more.

Service Offerings
Apollo Hospitals Enterprises also provides:

  • Project consultancy
  • Health insurance
  • Medical education through medical colleges and e-learning platforms
  • Research services

It manages various healthcare establishments, including pharmacies, clinics, dialysis centers, and specialized health centers. Notably, it engages in bio-banking of tissues and runs Apollo 24/7, a digital health mobile platform.

Financial Performance
The company has reported a trailing twelve months revenue of Rs. 21,313 Crores, demonstrating significant growth of 51.7% over the past three years. Apollo Hospitals Enterprises also returns value to its shareholders, distributing dividends with a yield of 0.35% per year, amounting to Rs. 25 per share in the last 12 months.

Industry Group:Healthcare Services
Employees:83,147
Website:www.apollohospitals.com

Important Disclosure & Data Context

This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.

Sharesguru Stock Score

APOLLOHOSP

47/100
Sharesguru Stock Score

APOLLOHOSP

47/100

Performance Comparison

APOLLOHOSP vs Healthcare (2021 - 2025)

APOLLOHOSP is underperforming relative to the broader Healthcare sector and has declined by 0.0% compared to the previous year.